A call for case studies was circulated in September 2018 for real life examples of Best Buys, Wasted Buys and Contestable Buys in low- and middle-income countries. 58 case studies from 30 countries were submitted and one of the chosen feature case studies was authored by Pempa from Health Technology

We got a chance to interview Sumithra Krishnamurthy and Jesse B. Bump from Harvard University, authors of Chapter 2 on Non-Communicable Diseases (NCDs), NCD Program Managers, and the Politics of Progress, to find out a bit more about their chapter. Read on to hear more!Q : Can you please tell us in

(Reuters Health) – For people conscious about their heart health, a new study suggests it may be best to eat fish instead of taking individual omega-3 fatty acids in supplement form.After reviewing information on the habits and fatty-acid blood levels of more than 20,000 male doctors, researchers fo

Finding true north is important for accurate navigation to embarking on the right path. While there may be many paths to making policy decisions, the ultimate goal is to end up with a decision that has been well-informed by evidence. Evidenced-based policy decisions result in more transparent and ef

As countries being their COVID-19 vaccinationation campaigns, an increasing number of public and private sectors in many settings are considering the introduction of COVID-19 vaccination certificates or similar instruments as a safe passage into the new normal. By facilitating the resumption of trav

Abstract Aim Kidney failure patients in the Philippines have free choice on their kidney replacement therapy (KRT), with a majority choosing haemodialysis (HD) over peritoneal dialysis (PD) and transplantation despite the inadequate coverage of HD. Although national health insurance coverage is

The Union of Myanmar is the largest country in mainland South-East Asia with a population of 57.5 million. It has a pluralistic mix of public and private healthcare systems. Although the Ministry of Health (MoH) is the main organisation responsible for healthcare provision, 70-80% of health service expenditure is now absorbed by the households. Thi

The drug, linaclotide, will be sold under the brand name Linzess and carry a boxed warning that it should not be used in patients 16 or younger, the agency said.An estimated 63 million people suffer from chronic constipation, according to the National Institutes of Health. Additionally, an estimated

Factors Affecting Health-Care Costs and Hospitalizations among Diabetic Patients in Thai Public Hospitals. Chaikledkaew U1,2, Pongchareonsuk P1, Chaiyakunapruk N3,4,5, Ongphiphadhanakul B6. 1Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok,Thailand; 2Health Interventio

The Food and Drug Administration has agreed to give priority status to its review of three new uses for the anticlotting drug Xarelto, Johnson & Johnson announced Monday.The company is asking the agency to approve the drug to treat deep vein thrombosis and pulmonary embolism, and to prevent recu